Leerink Partnrs Has Strong Estimate for A Q1 Earnings

Key Points

• Analysts at Leerink Partnrs have increased their Q1 2026 earnings per share estimate for Agilent Technologies from $1.34 to $1.38.
• Agilent Technologies reported a 10.1% increase in revenue year-over-year, totaling $1.74 billion for the last quarter.
• The company announced a quarterly dividend of $0.248 per share, reflecting an annualized yield of 0.7% and a payout ratio of 23.24%.

Agilent Technologies, Inc. (NYSE:A - Free Report) - Analysts at Leerink Partnrs boosted their Q1 2026 earnings per share (EPS) estimates for shares of Agilent Technologies in a research report issued to clients and investors on Monday, October 13th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn $1.38 per share for the quarter, up from their prior forecast of $1.34. The consensus estimate for Agilent Technologies' current full-year earnings is $5.58 per share. Leerink Partnrs also issued estimates for Agilent Technologies' FY2026 earnings at $5.94 EPS and FY2027 earnings at $6.52 EPS.

Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $1.32 EPS. The firm's revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS.

Several other analysts have also issued reports on A. Weiss Ratings reissued a "hold (c)" rating on shares of Agilent Technologies in a report on Wednesday, October 8th. UBS Group raised Agilent Technologies from a "neutral" rating to a "buy" rating and raised their price objective for the company from $130.00 to $170.00 in a research note on Wednesday, October 8th. Rothschild & Co Redburn began coverage on Agilent Technologies in a research report on Wednesday, October 8th. They issued a "buy" rating and a $165.00 target price for the company. Barclays increased their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a research report on Thursday, October 2nd. Finally, Wells Fargo & Company raised their price objective on Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a research report on Monday, September 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $149.62.

Agilent Technologies Stock Performance

A opened at $139.14 on Thursday. The firm has a market cap of $39.45 billion, a P/E ratio of 32.66, a price-to-earnings-growth ratio of 4.51 and a beta of 1.26. Agilent Technologies has a 52-week low of $96.43 and a 52-week high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The business's fifty day moving average is $126.49 and its 200-day moving average is $117.46.

Institutional Trading of Agilent Technologies

A number of hedge funds have recently bought and sold shares of the business. CWM LLC lifted its holdings in Agilent Technologies by 21.2% during the third quarter. CWM LLC now owns 70,390 shares of the medical research company's stock worth $9,035,000 after acquiring an additional 12,294 shares during the period. BSW Wealth Partners raised its stake in shares of Agilent Technologies by 5.3% in the third quarter. BSW Wealth Partners now owns 5,597 shares of the medical research company's stock valued at $718,000 after buying an additional 281 shares during the period. Harbor Capital Advisors Inc. raised its stake in shares of Agilent Technologies by 2.6% in the third quarter. Harbor Capital Advisors Inc. now owns 4,897 shares of the medical research company's stock valued at $629,000 after buying an additional 125 shares during the period. Swedbank AB raised its stake in shares of Agilent Technologies by 2.1% in the third quarter. Swedbank AB now owns 164,020 shares of the medical research company's stock valued at $21,052,000 after buying an additional 3,404 shares during the period. Finally, DAVENPORT & Co LLC raised its stake in shares of Agilent Technologies by 2,466.0% in the third quarter. DAVENPORT & Co LLC now owns 253,234 shares of the medical research company's stock valued at $32,503,000 after buying an additional 243,365 shares during the period.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies's payout ratio is presently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.